A new path forward for women living with period and pelvic pain

Uncovering the biology driving debilitating symptoms

A new path forward for women living with period and pelvic pain

July 1, 2026
Uncovering the biology driving debilitating symptoms
Read Transcript

The challenge

Pain associated with menstruation and conditions such as endometriosis is highly prevalent and can significantly affect quality of life, limiting participation in physical, educational and social activities. 

Among adolescents, up to 90% report experiencing period pain, and around 20% miss out on activities as a result. In adulthood, around 25% of women are reported to experience chronic pelvic pain – defined as pain lasting more than six months. 

While hormonal and other medications can provide relief for some, there remains a group of women whose pain is extremely difficult to manage. Researchers at Murdoch Children's Research Institute are seeking to better understand why.

The research

Researchers are investigating the role that inflammation may play in period and pelvic pain. By comparing inflammatory markers in women with and without pain across different stages of the menstrual cycle, the team hopes to identify the biological processes that drive period and pelvic pain. 

Importantly, this type of exploration has successfully led to novel treatments for pain associated with migraines and sickle cell disease – by identifying the inflammatory marker that is driving the pain and then repurposing known drugs for new indications.

The role of philanthropy

By supporting researchers to explore new approaches to understanding the biological drivers of period and pelvic pain, philanthropy is helping unlock the potential for more targeted treatment options for women whose symptoms remain difficult to manage.

What this could unlock

Hearts & Minds funding, as nominated by Munro Partners, has enabled this research to commence. If this research succeeds in identifying the inflammatory processes driving pain, clinicians may one day be able to identify women who could benefit from targeted treatments much earlier in their care.

The long-term goal is to offer women an alternative approach to managing period and pelvic pain, guided by a better understanding of the biological processes driving their symptoms.

Funding support from Hearts & Minds, as nominated by Core Fund Manager, Munro Partners. This content was last updated in July 2026. For further information, visit Murdoch Children's Research Institute.

The challenge

Pain associated with menstruation and conditions such as endometriosis is highly prevalent and can significantly affect quality of life, limiting participation in physical, educational and social activities. 

Among adolescents, up to 90% report experiencing period pain, and around 20% miss out on activities as a result. In adulthood, around 25% of women are reported to experience chronic pelvic pain – defined as pain lasting more than six months. 

While hormonal and other medications can provide relief for some, there remains a group of women whose pain is extremely difficult to manage. Researchers at Murdoch Children's Research Institute are seeking to better understand why.

The research

Researchers are investigating the role that inflammation may play in period and pelvic pain. By comparing inflammatory markers in women with and without pain across different stages of the menstrual cycle, the team hopes to identify the biological processes that drive period and pelvic pain. 

Importantly, this type of exploration has successfully led to novel treatments for pain associated with migraines and sickle cell disease – by identifying the inflammatory marker that is driving the pain and then repurposing known drugs for new indications.

The role of philanthropy

By supporting researchers to explore new approaches to understanding the biological drivers of period and pelvic pain, philanthropy is helping unlock the potential for more targeted treatment options for women whose symptoms remain difficult to manage.

What this could unlock

Hearts & Minds funding, as nominated by Munro Partners, has enabled this research to commence. If this research succeeds in identifying the inflammatory processes driving pain, clinicians may one day be able to identify women who could benefit from targeted treatments much earlier in their care.

The long-term goal is to offer women an alternative approach to managing period and pelvic pain, guided by a better understanding of the biological processes driving their symptoms.

Funding support from Hearts & Minds, as nominated by Core Fund Manager, Munro Partners. This content was last updated in July 2026. For further information, visit Murdoch Children's Research Institute.

Disclaimer: This material has been prepared by Hearts & Minds, published on July 1, 2026. HM1 is not responsible for the content of linked websites or content prepared by third party. The inclusion of these links and third-party content does not in any way imply any form of endorsement by HM1 of the products or services provided by persons or organisations who are responsible for the linked websites and third-party content. This information is for general information only and does not consider the objectives, financial situation or needs of any person. Before making an investment decision, you should read the relevant disclosure document (if appropriate) and seek professional advice to determine whether the investment and information is suitable for you.

facebook
linkedin
All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
December 5, 2023

Prof Misty Jenkins AO | 2023 Sohn Hearts & Minds Conference

At the 2023 Sohn Hearts & Minds Conference, we heard from Prof Misty Jenkins. Misty is a NHMRC fellow and laboratory head of the Immunology Division at the Walter and Eliza Hall Institute.

Read More
Daniel MacArthur speaking at the 2023 Sohn Hearts & Minds Conference in Sydney.Daniel MacArthur speaking at the 2023 Sohn Hearts & Minds Conference in Sydney.Daniel MacArthur speaking at the 2023 Sohn Hearts & Minds Conference in Sydney.Daniel MacArthur speaking at the 2023 Sohn Hearts & Minds Conference in Sydney.
November 15, 2023

Advancing Medicine Is In Daniel MacArthur’s DNA

When genomic scientist Daniel MacArthur had the opportunity to set up a new Centre for Population Genomics in Australia in 2019, he jumped at the chance to return home after 12 years living overseas.

Read More
November 10, 2023

Big thinkers in hunt for brain cancer cure

“Brain cancer is rare, but for people who do get it the prognosis is not good,” Assistant Professor Jenkins tells The Australian.

Read More
April 20, 2023

Artificial intelligence gives new hope for sufferers of severe heart problem

New AI software can improve the diagnosis of severe aortic stenosis by 72% and could potentially change the lives of about 50,000 Australians with the life-threatening condition.

Read More
February 14, 2023

Bringing Equity and Diversity to Genomic Medicine

Professor Daniel MacArthur, Director of the Centre for Population Genomics has big goals to bring equity and diversity into genomic medicine in Australia, something surprisingly inadequate presently.

Read More
September 6, 2022

VCCRI: 'Heart in a Box'

An Australian method of preserving donated hearts has boosted the number of successful transplants across the world, with new research demonstrating similar survival rates to traditional transplants.

Read More
February 24, 2022

Impact Video: Cerebral Palsy Alliance

This video features Professor Nadia Badawi AM, Professor Alistair McEwan, Paul Rayson and others discussing the incredible impact our partnership will have.

Read More
February 24, 2022

New Partnership with Cerebral Palsy Alliance

We’re excited to announce a new partnership with the Cerebral Palsy Alliance and are proud to be supporting this important research.

Read More
August 3, 2021

Australian breakthrough to stop heart arteries from clogging

Victor Chang scientist has led landmark research that has the potential to stop arteries of the heart from becoming clogged by targeting a particular gene.

Read More
October 12, 2020

Beneficiary Profile: Victor Chang

Cardiovascular disease is the number one cause of death globally and costs the Australian economy $12 billion each year. Every 12 minutes, one Australian dies from the disease. This is why the Victor Chang Cardiac Research Institute is dedicated to finding cures through their world class research.

Read More
September 23, 2020

Silent wave' of brain damage could follow pandemic

Australia urgently needs to prepare for a "silent wave" of COVID-19, which appears to be taking the form of long-term neurological side effects following infection with the virus.

Read More
September 8, 2020

Beneficiary Profile: Black Dog Institute

1 in 5 of us will experience symptoms of mental illness in any given year. In Australia that’s around 5 million people. And roughly 60% of these people won’t seek help. Learn what Black Dog is doing to create a mentally healthier world for everyone.

Read More
August 10, 2020

Beneficiary Profile: RPA Green Light

Emergency departments are the frontline of health care, with one in seven Australians seeking help from a hospital emergency department every year. Our medical staff depend on research findings to help inform their responses to urgent patient needs.

Read More
July 7, 2020

Beneficiary Profile: The Florey

Every year, 4.7 million Australians are diagnosed with one of the conditions that the Florey study. That's why they believe everyone has a stake in medical research.

Read More
June 9, 2020

Beneficiary Profile: Orygen

1 in 5 young people will have experienced a depressive episode by the time they are 18. With thanks to Cooper Investors and Hearts & Minds, we have been able to put youth mental health on the global agenda and progress our work in developing a global mental health framework.

Read More